Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
06/2006
06/28/2006EP1353689B9 Immunizing compositions and methods of use
06/28/2006EP1329460B1 Method of monomerizing human serum albumin polymers
06/28/2006EP1268783B1 Antiangiogene Eigenschaften von Matin und Fragmenten oder Varianten davon
06/28/2006EP1224290B1 Disulfide conjugated cell toxins and methods of making and using them
06/28/2006EP1218031B1 Pharmaceutical composition comprising an antigen
06/28/2006EP1157034B1 Process for production of diphtheria toxin
06/28/2006EP1062237B1 Ribonucleotide polypeptides containing metal
06/28/2006EP0990041B1 Regulation of transcription in mammalian cells and viral replication by a tetracyclin repressor
06/28/2006EP0970119B9 Synaptic activation protein compositions and method
06/28/2006EP0951548B9 Mammalian icyp (iodocyanopindolol)receptor and its applications
06/28/2006EP0936919B1 VARIANTS OF HUMAN CILIARY NEUROTROPHIC FACTOR (hCNTF) WITH A RANGE OF ACTION DIFFERENT FROM THAT OF THE WILD-TYPE MOLECULE
06/28/2006EP0935604B1 Magnetically activated cell sorting for production of proteins
06/28/2006EP0924990B1 Frozen food with antifreeze peptides
06/28/2006EP0895543B1 Method of stimulating an immune response by administration of host organisms that express intimin alone or as a fusion protein with one or more other antigens
06/28/2006EP0832227B9 Method for prolonging the expression of a gene of interest using soluble ctla4 molecules
06/28/2006EP0797676B9 Recombinant adenoviral vector and methods of use
06/28/2006EP0783585B1 DEFFECTIVE RECOMBINANT ADENOVIRUSES WITH INACTIVATED IVa2 GENE
06/28/2006EP0772774B1 Determination of a specific immunoglobulin using multiple antigens
06/28/2006EP0757722B1 HERPES VIRUS TRANSFORMED TO EXPRESS gD IN VITRO
06/28/2006EP0712414B1 Recombinant vector containing a lipoprotein gene sequence for expressing nucleotide sequences
06/28/2006EP0693129B1 Method of inhibiting the transcription of genes
06/28/2006EP0559729B1 Control of plant cell proliferation and growth
06/28/2006CN1795273A Use of a polypeptide
06/28/2006CN1795265A Control of stem cell differentiation induction and differentiation potency
06/28/2006CN1795206A Galectin 9-inducing factors
06/28/2006CN1795205A Spex compositions and methods of use
06/28/2006CN1795204A Method for the extraction of deer antler
06/28/2006CN1795203A Method for screening inhibitors of the gamma-secretase
06/28/2006CN1795202A Metal chelate complexes immobilized on solid supports for peptide preparation
06/28/2006CN1795007A Methods and compositions for the treatment of gastrointestinal disorders
06/28/2006CN1795005A Medicine health-care usage of globefish I collagen extration and preparing process thereof
06/28/2006CN1793369A Recombined 3-type parainfluenza viruse nuclelc shell protein and process for preparing antibody thereof
06/28/2006CN1793368A Anti-arsenic genome in linear plasmid of streptomycete
06/28/2006CN1793367A Tubercle bacillus recombined protein and expressing purefying method and application thereof
06/28/2006CN1793366A Salt resistant gene from salt mustard and its coding protein and application thereof
06/28/2006CN1793365A Salt resistant gene from salt mustard and its coding protein and application thereof
06/28/2006CN1793364A Salt resistant gene of salt mustard and its coding protein and application thereof
06/28/2006CN1793363A cDNA sequence of dehydrolysis responding transcription factor DREB gene of wheal
06/28/2006CN1793177A Recombined collagen and synthesizing and expressing purifying process thereof
06/28/2006CN1793176A Rat's IL-17RE span film region and cell inner region poly peptide and coding sequence, fusion protein and clone
06/28/2006CN1793175A Cell shifting related protein and its coding gene and application
06/28/2006CN1793174A Anti-cancer active protein of syngnathus
06/28/2006CN1793173A Process for preparing agglutinin of loranthyl
06/28/2006CN1793172A Non-inducing expressing gene engineering strain and structural process and application thereof
06/28/2006CN1793171A HPV16L1 protein analogous peptide and application for preparing HPV16 diagnostic agent and vaccine
06/28/2006CN1793170A Polypeptide of inhibiting HIV virus fusion and application thereof
06/28/2006CN1793168A Process for preparing anticencer active protein of thick muzzle syngnathus
06/28/2006CN1793167A Process for producing plant concentration protein
06/28/2006CN1261589C A beta-peptide screening method
06/28/2006CN1261581C Novel constructs for controlled expression of recombinant proteins in prokaryotic cells
06/28/2006CN1261579C Hybrid proteins which form heterodimers
06/28/2006CN1261572C Pesticidal toxins and genes from i-bacillus laterosporus strains
06/28/2006CN1261571C Microbial swollenin protein, DNA sequences encoding
06/28/2006CN1261570C Actinia neurotoxin gene and its application
06/28/2006CN1261453C Platelet-derived growth factor D, DNA coding and uses thereof
06/28/2006CN1261452C Sugar conjugated material CHB extracted from serum of turtle or/and tortoise, preparation process and application in pharmacy thereof
06/28/2006CN1261451C Silicatein-mediated synthesis of amorphous silicates and siloxanes and use thereof
06/27/2006US7067722 Nucleic acid sequences and methods of use for the production of plants with modified polyunsaturated fatty acids
06/27/2006US7067717 Isolated gene controlling disease resistance activity in plants and use thereof
06/27/2006US7067716 Methods and compositions for the introduction of molecules into cells
06/27/2006US7067713 C1 Inhibitor produced in the milk of transgenic non-human mammals
06/27/2006US7067698 Preparation of preferential oligomers for use as therapeutic tools; obtain oligomer, incubate with amines, expose to guanidinylation reagent, recover oligomer
06/27/2006US7067649 Includes an endothelial specific enhancer element; especially modifications of the PPE promoter, which enhance its expression in response to hypoxia and angiogenesis.
06/27/2006US7067648 Regulatory sequences of the mouse villin gene—use in transgenesis
06/27/2006US7067646 Methods and compositions for modulating tumor suppression
06/27/2006US7067645 useful for the visualization of protein localization and trafficking in living cells and as indicators of ectopic gene expression, thereby providing means to screen and/or select a sub-population of cells or trace cell lineage development
06/27/2006US7067643 Nucleases and exonucleases; radiolabelling, fluorescence
06/27/2006US7067642 expression vectors; transformed cells; useful in diagnosing and treating conditions including cancer
06/27/2006US7067639 Method to provide bacterial ghosts provided with antigens
06/27/2006US7067637 having mitogenic and/or differentiation-inductive, e.g. osteo-inductive potential, which is coded by DNA sequences coding for new members of the TGF- beta protein family
06/27/2006US7067636 Nucleotide sequences coding membrane protein for use as antiproliferative/antitumor/antiinflammatory/anticarcinogenic agents
06/27/2006US7067635 For use in diagnostic methods, immunotherapy, gene therapy and as vaccines
06/27/2006US7067633 mutant dynein light chain-1/protein inhibitor of nitric oxide synthase polypeptide; comprises a DLC1/PIN polypeptide lacking serine 88 of DLC1/PIN, a DLC1/PIN polypeptide lacking the C-terminal 19 amino acids of DLC1/PIN, and/or a DLC1/PIN polypeptide lacking the C-terminal 23 amino acids of DLC1/PIN
06/27/2006US7067632 VP22 proteins and uses thereof
06/27/2006US7067631 Fused DNA sequence, fused protein expressed from said fused DNA sequence and method for expressing said fused protein
06/27/2006US7067630 Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof
06/27/2006US7067629 Sodium channel in dorsal root ganglia
06/27/2006US7067628 PRO788 polypeptides
06/27/2006US7067627 Schizophrenia associated genes, proteins and biallelic markers
06/27/2006US7067626 Human ion channel proteins
06/27/2006US7067625 Isolated TWIK-1 potassium channel proteins
06/27/2006US7067624 Antimicrobial proteins
06/27/2006US7067621 Multifunctional context-activated protides and methods of use
06/27/2006US7067619 Integrin-binding peptides
06/27/2006US7067617 Polypeptides for use in artifically controlling gene expression
06/27/2006US7067496 Transplanting into dermis, least one hair follicle that has been modified ex vivo to contain nucleic acid molecule to introduce nucleic acid molecule into mammal
06/27/2006US7067490 Hepta-, Octa-and nonapeptides having antiangiogenic activity
06/27/2006US7067488 Modified GLP-1 peptides with increased biological potency
06/27/2006US7067487 Amino acid sequence having homology with amino acid position 194 to 220 in a pestiviral Erns protein RNase, from 59-88 in a L3 loop of a cytotoxic RNase of a ribosome-inactivating protein, or 187- 223 in respiratory syncytial virus
06/27/2006US7067485 IGF-I composition and its use
06/27/2006US7067484 AL-1 neurotrophic factor treatments
06/27/2006US7067480 Compositions and methods of use for anti-inflammatory agents
06/27/2006US7067477 Canine erythropoietin gene and recombinant protein
06/27/2006US7067475 Polypeptides; angiogenesis inhibitor; antitumor agents
06/27/2006US7067474 A peptide or polypeptide obtained from the armadillo domain of human beta -catenin polypeptide which inhibits the interaction of human beta -catenin polypeptide and a transcription factor or tumor suppressor protein
06/27/2006US7067473 Human neurotrophic polypeptide containing an amino acid sequence of 113 amino acids
06/27/2006US7067472 Administering an OB-receptor agonist ligand (which is a recombinant human OB protein, also known as leptin) for conferring resistance to endotoxic shock in an animal in need of resistance to endotoxic shock
06/27/2006US7067321 Polyglutamine repeat sequences
06/27/2006US7067317 Wound healing agent
06/27/2006US7067314 Monoclonal antibody, its immunoreactive fragment and hybridoma